Adiposogenital dystrophy pathophysiology

Adiposogenital dystrophy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Adiposogenital dystrophy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Head X Ray
CT
MRI
Vision Test
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Adiposogenital dystrophy pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Adiposogenital dystrophy pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Adiposogenital dystrophy pathophysiology
CDC on Adiposogenital dystrophy pathophysiology
Adiposogenital dystrophy pathophysiology in the news
Blogs on Adiposogenital dystrophy pathophysiology
Directions to Hospitals Treating Adiposogenital dystrophy
Risk calculators and risk factors for Adiposogenital dystrophy pathophysiology

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

The pathogenesis of adiposogenital dystrophy is believed to result from damage to the hypothalamus which links the nervous system to the endocrine system through the pituitary gland.

Pathophysiology

The pathogenesis of adiposogenital dystrophy is believed to result from damage to the hypothalamus (arcuate nucleus and ventromedial nuclei) which links the nervous system to the endocrine system through the pituitary gland."Froelich Syndrome - NORD (National Organization for Rare Disorders)".